Faculty and Staff News
Busha appointed associate dean for statewide system advancement
Michael E. Busha, MD, MBA, has been appointed to the new position of associate dean for statewide system advancement. Since 2010, Dr. Busha has served as an assistant professor of clinical family medicine for the Department of Family Medicine. Additionally, he serves as an assistant dean for graduate medical education.
“Growing our residencies statewide and optimizing our medical student services are just two of the many opportunities for synergy across our one statewide medical school. Dr. Busha not only brings his expertise from ambulatory improvement, he also brings people together to deliver higher outcomes,” said Peter Nalin, MD, executive associate dean for educational affairs.
In his new role, Dr. Busha will provide leadership to develop innovations that will advance the performance outcomes of educational offices and venues throughout the IU School of Medicine statewide system. This will entail strategies to further improve in areas such as student health services and advance the school’s statewide framework for clinical leadership of clerkships that prepare students for residencies.
Plenty of laughter, talent at this year?s Second Year Show
Last Friday evening, Friday the 13th, Jason finally found his funny bone in the third edition of Indiana University School of Medicine's Second Year Show. The event, conceived by current MS4s Ben Ulrich and Mike Johnston, annually brings together all nine campuses for a night of fun and laughter.
Seeking to take the event to new heights, Co-Presidents and MS2s Michael Clark and Austin Wininger turned the typically skit-based show into a cohesive, plot-driven musical theater production highlighting the most comedic aspects of the first year of medical school.
"The decision to make the change was incredibly intimidating, especially given the quality of past, skit-centric shows," Clark said. "However, before medical school I spent my whole life either performing or creating things for others to perform. I figured that among a class of 360, surely I wasn't alone and could find a group of people willing and excited to go on a fun, crazy journey with me. Fortunately, I was more right than I ever could have dreamed. Hidden talents abound within the Class of 2019."
Thanks to a dedicated core cast of 10 MS2s, more than 50 others in supporting roles, and the tireless work of the 18-member 2YS executive board, the show was presented for more than 300 people at the Madame Walker Theatre in downtown Indianapolis. Executive Vice President of Music Justin Woods recalled the sense of unity that culminated the year-long preparation process. "We had a pretty ambitious plan for the show, but to have everyone come together in the final days to make it happen was really cool," he said.
That unity was echoed by fellow MS2 Jason Hoard, who said, “It was great to work with fellow students on such a well-envisioned and fun project and to see my classmates' talent and hard work come to life in something very different from our day-to-day life in medical school."
Elive Likine, MS2 and an executive vice president of writing, drew parallels between what it takes to make 2YS work and the success of a medical team. "Physicians live to serve and serve to live, and the theater is no different,” he said.
Faculty members in attendance at the show were equally enthusiastic about the students’ performance. “It was a pleasure [to see the production] and I appreciate the efforts the students devoted to skits and video productions too,” said Peter Nalin, MD, executive associate dean for educational affairs.
“The 2YS was a great evening! It was wonderful to see the amazing talent possessed by the MS2 class statewide,” added Abigail Klemsz, MD, PhD, assistant dean, academic advising.
The class of 2019 was thrilled to receive a $1,000 check, presented at the end of the show by Dean Jay Hess, MD, MHSA, in recognition of above average completion rates on the Y2Q survey. The funds will be used for "Class of 2019" - Match Day or Senior Banquet.
Contreraz named administrator of IU Simon Cancer Center clinical trials office
Mario Contreraz is the new administrator of the IU Simon Cancer Center Clinical Trials Office (CTO), effective Monday, Jan. 16. As administrator, Contreraz will provide overall direction for the strategy and vision for the CTO to ensure all National Cancer Institute criteria and guidelines are met, including initiation, monitoring, completion and reporting of clinical studies in cancer research. Additional responsibilities include budget and fiscal management, quality assurance, database maintenance, proper documentation and reporting, and compliance with various policies and regulations. He will also serve as a liaison between the administrative staff and the sponsors, collaborators and regulatory agencies.
Joining the CTO in May 2016 as the research nurse administrator, Contreraz had served as interim administrator for the office during the recruitment process. Before coming to the CTO, Contreraz was a clinical research manager at the IU School of Medicine’s clinical research center, a clinical research nurse at the Krannert Institute of Cardiology, a nursing associate at Eli Lilly and an ER nurse at Eskenazi Health.
Drug testing standards for hemorrhagic stroke inadequately met, unevenly applied
Cocaine and amphetamine use are linked to a higher risk of intracerebral hemorrhage, but guidelines recommending drug screening for those stroke patients often weren't followed in a study of two academic teaching hospitals, Indiana University School of Medicine researchers reported.
The researchers found that the stroke patients were screened less than half the time. African-American patients, meanwhile, were significantly more likely to receive the drug screening than were other patients.
As the patients moved through the treatment process after being admitted to the hospital, "there were multiple opportunities for these patients (to be screened) and we all missed it," said Jason Mackey, MD, assistant professor of neurology and senior author of the paper, which was published online ahead of print in the journal Neurology.
"This was a compelling message that we needed to redesign our systems," Dr. Mackey said.
That redesign has already happened at one of the hospitals, IU Health Methodist Hospital in Indianapolis, he said. The hospital's order set--a checklist of hospital orders relevant to a patient's diagnosis--for intracerebral hemorrhage was changed so that ordering the drug screen is pre-checked. This ensures a drug screen will be performed unless a physician acts to uncheck the test in the order set.
The study's results indicate that hospital systems need to make systematic efforts to improve screening, the researchers said. More research also is needed to better understand the relationships between cocaine and amphetamine use and the incidence and outcomes from intracerebral hemorrhage, they said.
For more details, visit IU School of Medicine Newsroom.
Faculty and Staff News
Submit Trustee Teaching Award nominations by Jan. 27
The Indiana University Board of Trustees annually recognizes faculty excellence in teaching through a program known as the Trustee Teaching Awards. Excellence in teaching is the primary factor for selection.
Tenured and tenure-track faculty and librarians engaged in teaching are eligible, as are full-time clinical faculty and full-time lecturers whose primary duties are teaching, including IU School of Medicine faculty who may be located at medical centers or be paid by institutions other than Indiana University.
Award recipients must have demonstrated a sustained level of teaching excellence in the form of documented student learning. The nomination form is available at faculty.medicine.iu.edu, and all nominations are due Friday, Jan. 27. Questions? Email email@example.com.
CUPID summer oncology program seeks participants
Clinical faculty, laboratory mentors and lecturers are invited to participate in a joint summer translational oncology program among IU School of Medicine, IU Simon Cancer Center, and Johns Hopkins. The program--Cancer in the Under-Privileged Indigent or Disadvantaged (CUPID)--is designed to promote the field of oncology to medical students interested in addressing both rural and urban health care disparities. Fellows selected from IU will be assigned to laboratories and clinics in Indianapolis.
IU School of Medicine will host four to six students for the program, which will be held June 12 to July 28. Faculty conducting cancer-related research are encouraged to consider hosting a student in their labs, giving a lecture related to oncology or providing a shadow experience in their clinics. Faculty mentors hosting a summer student in their labs will receive $1,000 to cover lab-related expenses.
Chaplain services now available
IU School of Medicine Medical Student Education is launching a Spiritual Care Program. Professional board-certified and board-eligible interfaith chaplains with specialized training in providing spiritual care for people of all faiths are available. These Indiana University Health Academic Health Center chaplains are volunteering to provide spiritual, emotional, religious or cultural support services to students, faculty, staff and administrators.
Chaplains care for people seeking meaning and purpose in their lives, by offering active and empathetic listening, and by asking questions designed to connect people with their own personal, spiritual and religious resources. A chaplain will be available for walk-in hours in MS 166 from 11 am-1 pm on Tuesday, Jan. 24.
Register for March 17 pediatric GI conference
The IU School of Medicine Department of Pediatric Gastroenterology, Hepatology and Nutrition is hosting the Pediatric GI for the Primary Care Clinician conference from 7:30 am-noon, Friday, March 17, at Ritz Charles in Carmel.
The conference is designed for physicians and allied health care providers specializing in family medicine and pediatrics. The program will provide learners with updates in the clinical management of important and commonly seen pediatric disorders of gastroenterology, hepatology and nutrition.
Indy--Holocaust Remembrance Program is Jan. 26
Plan to attend the Holocaust Remembrance Program from 1:30-2:30 pm, Thursday, Jan. 26, in the IUPUI Campus Center Theater. The moving program includes a keynote by Tibor Klopfer of the Holocaust Education Center of Indiana speaking on "A Family's Experience--Hungarian Jews in the Holocaust"; remarks by Karen Dace, vice chancellor for diversity, equity and inclusion; a performance by the IUPUI University Choir; and a memorial candle-lighting by IUPUI students and faculty.
IU Simon Cancer Center joins others to endorse updated HPV vaccine guidance
Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), Indiana University Melvin and Bren Simon Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).
According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States. Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the country, with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series.
The new guidelines from the CDC recommend that children ages 11 to 12 should receive two doses of the HPV vaccine at least six months apart. Adolescents and young adults ages 15 and older should continue to complete the three-dose series.
"The two-dose regimen for those who initiate vaccination at age 14 or younger provides similar protection to the three-dose series, while reducing the cost and burden of vaccination," said Gregory Zimet, PhD, professor of pediatrics and clinical psychology in the Section of Adolescent Medicine at the IU School of Medicine and a researcher at the IU Simon Cancer Center.
For more, visit IU School of Medicine Newsroom.